文献速递系统性红斑狼疮

缓解与低疾病活动状态时间比例与系统性红斑狼疮患者生活质量改善相关:LUMINA(LXXIX)多民族多中心美国队列结果

Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort.
PubMed 文献 · RMD Open · 2019-05-23

线性回归调整潜在混杂因素后,缓解/LDAS时间比例越高,躯体与心理生活质量评分越好。

要点

  • 缓解/LDAS时间比例越高,SF-36躯体与心理评分越好
  • 调整混杂后PCS参数估计9.47(p<0.0001),MCS为5.89(p=0.0027)
  • 各子量表参数估计从心理健康7.51(p=0.0495)到角色躯体31.79(p<0.0001)

核心结论

  • 系统性红斑狼疮患者处于缓解/LDAS的时间比例与SF-36所测生活质量改善相关。

研究设计与样本

  • 以随访期间处于缓解/LDAS的时间比例为自变量,末次访视SF-36各维度为终点,采用线性回归分析。
  • 缓解定义为SLAM评分=0、泼尼松≤5 mg/天且未用免疫抑制剂;LDAS定义为未缓解但SLAM评分≤3、泼尼松≤7.5 mg/天且未用免疫抑制剂。

主要发现

  • 调整潜在混杂因素后,缓解/LDAS时间比例与更好的生活质量相关。
  • PCS参数估计为9.47(p<0.0001),MCS为5.89(p=0.0027)。
  • SF-36子量表参数估计从心理健康7.51(p=0.0495)到角色躯体31.79(p<0.0001)。

关键数值与推荐

  • 缓解:SLAM评分=0、泼尼松≤5 mg/天且无免疫抑制剂。
  • LDAS:未达缓解、SLAM评分≤3、泼尼松≤7.5 mg/天且无免疫抑制剂。
  • 终点为末次访视SF-36的PCS、MCS及各个子量表。

临床怎么用

  • 在SLE管理中可将延长缓解/LDAS时间作为改善患者生活质量的 achievable 目标。
  • 评估疗效时除疾病活动度外,应同时关注SF-36所反映的躯体与心理生活质量。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To determine whether the proportion of time systemic lupus erythematosus patients achieve remission/low disease activity state (LDAS) is associated with a better quality of life (QoL). PATIENTS AND METHODS: Patients from a well-established multiethnic, multicentre US cohort were included: remission: Systemic Lupus Activity Measure (SLAM) score=0, prednisone≤5 mg/day and no immunosuppressants); LDAS not in remission, SLAM score≤3, prednisone≤7.5 mg/day, no immunosuppressants; the combined proportion of time patients were in these states was the independent variable. The endpoints were the Physical and Mental Components Summary measures (PCS and MCS, respectively) and the individual subscales of the Short Form (SF)-36 at the last visit. Linear regression was used to estimate the association between the proportion of follow-up time in remission/LDAS and the SF-36 measures with and without adjustment for possible confounders. RESULTS: Four hundred and eighty-three patients were included. The per cent of time on remission/LDAS was associated with better QoL after adjusting for potential confounders; for the PCS the parameter estimate was 9.47 (p<0.0001), for the MCS 5.89 (p=0.0027), and for the subscales they ranged between 7.51 (p=0.0495) for mental health and 31.79 (p<0.0001) for role physical. CONCLUSIONS: The per cent of time lupus patients stay on remission/LDAS is associated with a better QoL as measured by SF-36.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Ugarte-Gil MF, Pons-Estel GJ, Vila LM, et al. Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort. RMD Open. 2019. PMID: 31245057. doi:10.1136/rmdopen-2019-000955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。